We are live on
!
Find out more
OI
Oakbrook Investments Portfolio holdings
AUM
$39.2M
1-Year Est. Return
3.66%
This Fund
S&P 500
This Quarter
Est. Return
+5.09%
1 Year Est. Return
-3.66%
3 Year Est. Return
+26.09%
5 Year Est. Return
+53.43%
10 Year Est. Return
–
AUM
$1.64B
AUM Growth
-$169M
(-9.3%)
Cap. Flow
-$237M
Cap. Flow
% of AUM
-14.49%
Top 10 Holdings %
Top 10 Hldgs %
20.83%
Holding
617
New
61
Increased
87
Reduced
371
Closed
75
Avg Time Held
7.2
quarters
Top 10 Avg Time Held
6.3
quarters
Top 20 Avg Time Held
6.5
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$10M |
| 2 |
RTX Corp
RTX
|
+$8.37M |
| 3 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$6.71M |
| 4 |
UnitedHealth
UNH
|
+$4.6M |
| 5 |
Pfizer
PFE
|
+$4.49M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Aerospace
GE
|
+$20.1M |
| 2 |
ExxonMobil
XOM
|
+$14M |
| 3 |
Agilent Technologies
A
|
+$10.2M |
| 4 |
Procter & Gamble
PG
|
+$9.82M |
| 5 |
CME Group
CME
|
+$7.61M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.64% |
| 2 | Technology | 15.17% |
| 3 | Financials | 14.71% |
| 4 | Industrials | 13.22% |
| 5 | Consumer Staples | 11.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
PepsiCo
PEP
$173B
| $43.4M | 2.65% |
398,841
-37,840
| -9% | -$4.08M |
2013 Q2
13 quarters
|
|
2
Amgen
AMGN
$223B
| $35.9M | 2.19% |
215,183
-42,460
| -16% | -$7.18M |
2013 Q2
13 quarters
|
|
|
3
Procter & Gamble
PG
$355B
| $35M | 2.14% |
390,445
-113,110
| -22% | -$9.82M |
2013 Q2
13 quarters
|
|
4
Apple
AAPL
$4.98T
| $34.1M | 2.08% |
1,205,572
-226,200
| -16% | -$5.99M |
2013 Q2
13 quarters
|
|
|
5
GE Aerospace
GE
$319B
| $34M | 2.08% |
239,808
-135,030
| -36% | -$20.1M |
2013 Q2
13 quarters
|
|
6
Alphabet (Google) Class A
GOOGL
$4.33T
| $33.8M | 2.07% |
841,100
-64,400
| -7% | -$2.52M |
2015 Q4
3 quarters
|
|
7
Medtronic
MDT
$119B
| $32.9M | 2.01% |
380,886
-53,530
| -12% | -$4.66M |
2013 Q2
13 quarters
|
|
8
Gilead Sciences
GILD
$183B
| $31.4M | 1.92% |
396,635
+6,195
| +2% | +$503K |
2013 Q2
13 quarters
|
|
9
Qualcomm
QCOM
$189B
| $30.2M | 1.85% |
441,587
-61,740
| -12% | -$3.75M |
2013 Q2
13 quarters
|
|
10
Autodesk
ADSK
$48.2B
| $30M | 1.84% |
415,432
-81,946
| -16% | -$5.16M |
2013 Q2
13 quarters
|
|
|
VAR
11
DELISTED
Varian Medical Systems, Inc.
VAR
| $28.1M | 1.72% |
322,346
+82,296
| +34% | +$6.71M |
2016 Q2
1 quarter
|
|
12
Nike
NKE
$52.5B
| $27.6M | 1.69% |
525,112
-55,491
| -10% | -$3.13M |
2013 Q2
13 quarters
|
|
13
Automatic Data Processing
ADP
$109B
| $27.3M | 1.67% |
309,220
+14,785
| +5% | +$1.34M |
2013 Q2
13 quarters
|
|
14
Merck
MRK
$350B
| $26.1M | 1.59% |
438,258
-76,448
| -15% | -$4.47M |
2013 Q2
13 quarters
|
|
15
McCormick & Company Non-Voting
MKC
$12B
| $26M | 1.59% |
520,120
-75,320
| -13% | -$3.82M |
2014 Q1
10 quarters
|
|
16
Microsoft
MSFT
$4.04T
| $25.7M | 1.57% |
445,582
-60,400
| -12% | -$3.41M |
2013 Q2
13 quarters
|
|
17
SLB Ltd
SLB
$72.4B
| $25.3M | 1.54% |
321,085
+21,085
| +7% | +$1.67M |
2013 Q2
13 quarters
|
|
18
Walt Disney
DIS
$187B
| $24.5M | 1.49% |
263,305
-41,415
| -14% | -$3.97M |
2013 Q2
13 quarters
|
|
|
19
CME Group
CME
$100B
| $22.9M | 1.4% |
219,405
-72,885
| -25% | -$7.61M |
2013 Q2
13 quarters
|
|
20
Johnson Controls International
JCI
$94.8B
| $20.7M | 1.27% |
445,752
-107,025
| -19% | -$4.96M |
2015 Q1
6 quarters
|
|
21
Caterpillar
CAT
$355B
| $20.3M | 1.24% |
228,170
-31,835
| -12% | -$2.6M |
2013 Q2
13 quarters
|
|
22
W.W. Grainger
GWW
$62.4B
| $20.2M | 1.24% |
89,945
-12,950
| -13% | -$2.91M |
2014 Q3
8 quarters
|
|
23
United Parcel Service
UPS
$80.6B
| $19.5M | 1.19% |
177,994
-25,885
| -13% | -$2.83M |
2013 Q2
13 quarters
|
|
24
Western Union
WU
$1.9B
| $19.1M | 1.17% |
916,315
-131,285
| -13% | -$2.7M |
2013 Q2
13 quarters
|
|
25
Amazon
AMZN
$2.79T
| $18.9M | 1.15% |
450,580
-42,000
| -9% | -$1.61M |
2013 Q2
13 quarters
|
|
Similar funds
MF
AIM
QCMA
SC
BIM
GP
GAM
SCM
Oakbrook Investments's Q3 2016 Portfolio in Review
As of Q3 2016, Oakbrook Investments held 617 positions worth $1.64B, down 9.3% from $1.81B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Oakbrook Investments withdrew a net $237M in Q3 2016, closing 75 positions and reducing 371 holdings. Its most notable exit was Occidental Petroleum, an estimated $7.36M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 17% a quarter earlier, followed by Technology and Financials.
Against the trend, Oakbrook Investments opened a new position in Praxair Inc worth $3.98M.
- Oakbrook Investments's largest Q3 2016 buy was Praxair Inc: 32,900 shares worth $3.98M.
- Oakbrook Investments added most to Intel in Q3 2016, an estimated $10M increase.
- Oakbrook Investments's biggest Q3 2016 reduction was GE Aerospace, cutting an estimated $20.1M.
- Oakbrook Investments fully exited Occidental Petroleum in Q3 2016, selling an estimated $7.36M.
- Oakbrook Investments's ten largest holdings make up 21% of its $1.64B portfolio in Q3 2016.
- Oakbrook Investments opened 61 new positions and closed 75 in Q3 2016.
- Oakbrook Investments's portfolio value fell 9.3% quarter-over-quarter to $1.64B.
Based on Oakbrook Investments's 13F filing for Q3 2016, filed 21 Oct 2016.